Legislation
- Title
- Public Health - Essential Off-Patent or Generic Drugs - Price Gouging - Prohibition
- Sponsored by
- The Speaker (By Request - Office of the Attorney General) and Delegates Bromwell, Anderson, Atterbeary, Barkley, B. Barnes, D. Barnes, Barron, Barve, Beidle, Brooks, Carr, Chang, Clippinger, Conaway, Cullison, Davis, Dumais, Ebersole, Fennell, Fraser-Hidalgo, Frick, Frush, Gaines, Gilchrist, Glenn, Gutierrez, Hayes, Haynes, Healey, Hettleman, Hill, Hixson, Holmes, C. Howard, Jackson, Jalisi, Jameson, Jones, Kelly, Knotts, Krimm, Lafferty, Lam, R. Lewis, Lierman, Lisanti, Luedtke, McCray, McIntosh, A. Miller, Moon, Morales, Oaks, Patterson, Pena-Melnyk, Platt, Proctor, Queen, Reznik, Robinson, Rosenberg, Sample-Hughes, Sanchez, Sophocleus, Stein, Sydnor, Tarlau, Turner, Valderrama, Vallario, Waldstreicher, Walker, A. Washington, M. Washington, C. Wilson, K. Young, P. Young, Pendergrass, Angel, Kipke, McDonough, Metzgar, Miele, Saab, West, Aumann, Carey, Mautz, and S. Howard
- Status
- Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 818
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Prohibiting a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug; establishing that it is not a violation of a specified provision of the Act for a wholesale distributor to increase a price of an essential off-patent or generic drug under specified circumstances; authorizing the Maryland Medical Assistance Program to notify the Attorney General of an increase in the price of an essential off-patent or generic drug under specified circumstances; etc.
Committees
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
2-801 through 2-803 )
Last Updated: 2/3/2020 2:30 PM